VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
Apple Inc. vs Alcon Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Apple Inc.
AAPL · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Alcon Inc.
ALC · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Apple Inc. leads (87 / 100 vs 71 / 100 for Alcon Inc.).
- Segment focus: Apple Inc. has 5 segments (50.4% in iPhone); Alcon Inc. has 2 segments (56% in Surgical).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Apple Inc. has 7 moat types across 3 domains; Alcon Inc. has 7 across 3.
Primary market context
Apple Inc.
iPhone
Smartphones (with focus on premium smartphones and iOS ecosystem devices)
Global
Consumers and enterprises (end-users), plus carrier/retail channels
OEM / platform owner
50.4%
Alcon Inc.
Surgical
Ophthalmic surgical devices (implantables, consumables, equipment) and related service/training
Global
Ophthalmic surgeons, hospitals, ambulatory surgery centers, group purchasing organizations
Medical device OEM with direct service, clinical support, and training
56%
Side-by-side metrics
Moat coverage
Shared moat types
Apple Inc. strengths
Alcon Inc. strengths
Segment mix
Apple Inc. segments
Full profile >iPhone
Oligopoly
Mac
Oligopoly
iPad
Oligopoly
Wearables, Home and Accessories
Competitive
Services
Quasi-Monopoly
Alcon Inc. segments
Full profile >Surgical
Oligopoly
Vision Care
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.